Category:
Chiral Intermediates
CAS NO:
863971-44-2
Standard:
In-house Standards,
/
Tripeptide (MMAE-3) is a cytotoxic linker-drug conjugate component used in Antibody-Drug Conjugates (ADCs). It features a valine-citrulline dipeptide sequence cleaved by lysosomal proteases. The core structure relies on MMAE (Monomethyl Auristatin E) payload attachment via maleimide chemistry. Precise synthesis ensures high purity for therapeutic efficacy.
Strictly handle under controlled temperature (-20°C) to maintain stability. Avoid direct contact due to potent cytotoxicity; use appropriate PPE and engineering controls during processing. Not for direct human administration without formulation into approved ADCs.